Long intergenic noncoding RNA–nucleotide metabolism regulator (lincNMR (MAP3K9-DT))

Long intergenic noncoding RNA–nucleotide metabolism regulator (lincNMR/MAP3K9-DT) is a lincRNA, a type of long noncoding RNA transcribed from intergenic regions of the genome and not overlapping protein-coding genes[3]. As a divergent transcript, its transcription start site is adjacent to the MAP3K9 gene locus, but it itself does not encode a protein. Divergent lncRNAs frequently play roles in regulating gene expression of neighboring mRNA loci through mechanisms such as chromatin modification, recruitment of histone modifiers, and epigenetic regulation, as described for other lincRNAs in experimental systems[3][1][2]. The specific biological actions, disease associations, and potential as a drug target for lincNMR/MAP3K9-DT have not been reported, and there is no evidence of interacting drugs or biomarker/research tool development. Summary of available information: - lincNMR/MAP3K9-DT is best classified as a **long intergenic noncoding RNA** ("lincRNA")[3]. - As a divergent transcript, its genomic arrangement is adjacent to the MAP3K9 gene. - No evidence currently supports its use as a therapeutic **target**, nor as a biomarker, nor association with disease, drug interaction, or specific safety concerns. - Its presumed function, in line with other lncRNAs, is regulation of gene expression and chromatin structure[3]. - All known aliases provided are correct. There are no clear naming errors or ambiguities; **is_incorrect** is false. If future research establishes disease links, drug interactions, or therapeutic relevance for lincNMR/MAP3K9-DT, these fields could be updated accordingly.

Other names

lincNMRMAP3K9 divergent transcriptMAP3K9-DTlong intergenic noncoding RNA–nucleotide metabolism regulator

Not applicable (no drugs known to target this molecule)